N-(5-chloro-2-propoxybenzyl)-N-(4-(N-(prop-2-yn-1-yl)sulfamoyl)phenethyl)benzo[d]thiophene-3-carboxamide

ID: ALA5208422

Chembl Id: CHEMBL5208422

PubChem CID: 168297490

Max Phase: Preclinical

Molecular Formula: C30H29ClN2O4S2

Molecular Weight: 581.16

Associated Items:

Names and Identifiers

Canonical SMILES:  C#CCNS(=O)(=O)c1ccc(CCN(Cc2cc(Cl)ccc2OCCC)C(=O)c2csc3ccccc23)cc1

Standard InChI:  InChI=1S/C30H29ClN2O4S2/c1-3-16-32-39(35,36)25-12-9-22(10-13-25)15-17-33(20-23-19-24(31)11-14-28(23)37-18-4-2)30(34)27-21-38-29-8-6-5-7-26(27)29/h1,5-14,19,21,32H,4,15-18,20H2,2H3

Standard InChI Key:  QTTOTSJPVAAYQL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5208422

    ---

Associated Targets(Human)

HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Nlrp3 NACHT, LRR and PYD domains-containing protein 3 (641 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
J774.A1 (2436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nlrc4 NLR family CARD domain-containing protein 4 (37 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aim2 Interferon-inducible protein AIM2 (37 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 581.16Molecular Weight (Monoisotopic): 580.1257AlogP: 6.14#Rotatable Bonds: 12
Polar Surface Area: 75.71Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.13CX Basic pKa: CX LogP: 6.27CX LogD: 6.27
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.20Np Likeness Score: -1.87

References

1. Xu Y, Xu Y, Blevins H, Guo C, Biby S, Wang XY, Wang C, Zhang S..  (2022)  Development of sulfonamide-based NLRP3 inhibitors: Further modifications and optimization through structure-activity relationship studies.,  238  [PMID:35635948] [10.1016/j.ejmech.2022.114468]

Source